Glioblastoma Market is expected to register a CAGR of 7.60% to reach USD 2416.33 million by 2030. Glioblastoma is a malignant grade IV tumour. The increasing incidence rates, the rise in product approvals, and growing research in the field are projected to drive the growth of the global glioblastoma market. On the other hand, the termination of many clinical trial drug candidates...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek